🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07183670
Enrolling by invitation Observational

A Voice Valve-Based Decannulation Protoco for Patients With a Prolonged Disorders of Consciousness

NCT07183670 · tracked via the Priya Life Science China tracker
Sponsor
Hongying Jiang, MD
Phase
Observational
Started
2026-02-01
Last updated
2026-07-31

Condition(s) studied

Prolonged Disorders of ConsciousnessTracheostomy

Investigational drug(s) / intervention(s)

decannulation protocol

decannulation protocol: Step 1: The patient's clinical stability is confirmed. Step 2: Tolerance to the speaking valve is assessed. Step 3: The wearing time of the speaking valve is extended continuously for 4 h, and no tracheostomy cannula is used for sputum suction within 4 h. Step 4: Cough strength is evaluated to be good before decannulation. Decannulation Criteria: Pass Step 1 + Step 2 + Step 3 + Step 4

Study summary

To evaluate the feasibility of a standardized tracheostomy decannulation protocol for patients with prolonged Disorders of Consciousness (pDoC) in rehabilitation hospitals.

Eligibility

Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: 1. Tracheostomy status 2. The duration of consciousness disorders\> 28 days 3. CRS-R score \>0 and \<17 4. Signed informed consent by legal representative Exclusion Criteria: 1. Non-PDOC tracheostomy patients 2. Death within 2 weeks post-referral

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Beijing Rehabilitation Hospital, Capital Medical University, Beijing,China Beijing Beijing Municipality
Beijing Rehabilitation Hospital, Capital Medical University Beijing China

More Hongying Jiang, MD trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07183670 on ClinicalTrials.gov ↗ ← All trials in China